☆ 4.7 Review

The Role of the Microbiome in Connective-Tissue-Associated Interstitial Lung Disease and Pulmonary Vasculitis

BIOMEDICINES (2022)

Related references

Note: Only part of the references are listed.

Review Biochemistry & Molecular Biology

Lung Microbiome in Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases

Francesco Amati et al.

Summary: Interstitial lung diseases are a complex group of diseases with unclear causes and mechanisms of progression. Recent research suggests that the lung microbiome may play a role in the development and progression of these diseases. However, the specific mechanisms are not yet understood. This review aims to discuss the role of altered lung microbiome in various interstitial lung diseases. Understanding the interaction between the host and microbiome in the lungs is a priority for research on these diseases.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection

Article Biochemistry & Molecular Biology

The composition of the lung microbiome differs between patients with dermatomyositis and rheumatoid arthritis associated with interstitial lung disease

Yueyan Lou et al.

Summary: Dermatomyositis and rheumatoid arthritis are inflammatory diseases that commonly lead to interstitial lung disease (ILD). Analysis of the lung microbiota composition in patients with these conditions revealed differences in diversity compared to healthy controls, with several unique microbial biomarkers distinguishing between the diseases. Predicted functional and metabolic alterations in the lung microbiota between rheumatoid arthritis, dermatomyositis, and healthy controls may lead to the development of biomarkers for identifying high-risk patients.

FEBS OPEN BIO (2022)

Add to Collection

Article Multidisciplinary Sciences

Inhibition of lung microbiota-derived proapoptotic peptides ameliorates acute exacerbation of pulmonary fibrosis

Corina N. D'Alessandro-Gabazza et al.

Summary: The authors demonstrate that a monoclonal neutralizing antibody against the proapoptotic peptide corisin, derived from the lung microbiota, can improve acute exacerbation of pulmonary fibrosis and the severity of endotoxin-induced acute lung injury in mice. The study provides insights into the processing and release of corisin and shows that an anticorisin monoclonal antibody can ameliorate lung fibrosis and acute lung injury. These findings highlight the role of corisin in the pathogenesis of the diseases and offer a novel approach to treating the incurable disease.

NATURE COMMUNICATIONS (2022)

Add to Collection

Review Medicine, General & Internal

Gut dysbiosis in rheumatic diseases: A systematic review and meta-analysis of 92 observational studies

Yilun Wang et al.

Summary: Dysbiosis in gut microbiota may be associated with the occurrence or development of rheumatic diseases. The review of existing evidence suggests that there is a decrease in alpha-diversity indices in rheumatic diseases, but the specific associations with different rheumatic diseases are inconsistent. Alterations in certain microbial populations in the gut may be related to rheumatic diseases.

EBIOMEDICINE (2022)

Add to Collection

Article Rheumatology

Association between systemic lupus erythematosus and disruption of gut microbiota: a meta-analysis

Shate Xiang et al.

Summary: Recent studies have shown that patients with SLE have imbalanced gut microbiota, characterized by decreased beneficial bacteria and increased harmful bacteria. A meta-analysis of 11 case-control studies demonstrated that SLE patients had lower diversity and richness of gut microbiota compared to healthy controls. Additionally, SLE patients had lower abundance of Ruminococcaceae and higher abundance of Enterobacteriaceae and Enterococcaceae. The use of high doses of glucocorticoids and hydroxychloroquine in SLE treatment was also found to have an impact on the gut microbiota.

LUPUS SCIENCE & MEDICINE (2022)

Add to Collection

Review Biochemistry & Molecular Biology

Microbiome Changes in Connective Tissue Diseases and Vasculitis: Focus on Metabolism and Inflammation

Lidia La Barbera et al.

Summary: The microbial community plays a vital role in maintaining homeostasis and immune functions through interactions with the host immune system. Dysbiosis, or altered microbial composition, can disrupt this balance and lead to the development of inflammatory diseases.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection

Article Immunology

Safety and efficacy of fecal microbiota transplantation for treatment of systemic lupus erythematosus: An EXPLORER trial

Cancan Huang et al.

Summary: This study conducted a trial of FMT in SLE patients, demonstrating that FMT may be a feasible, safe, and potentially effective therapy. By modifying the gut microbiome, FMT can improve symptoms in SLE patients.

JOURNAL OF AUTOIMMUNITY (2022)

Add to Collection

Review Medicine, General & Internal

Interstitial lung diseases

Marlies Wijsenbeek et al.

Summary: There are over 200 recognized interstitial lung diseases, which vary in rarity. Most of these diseases are characterized by inflammation or fibrosis in the interstitial space, leading to impaired gas exchange and resulting in symptoms such as breathlessness, decreased exercise tolerance, and reduced quality of life. The prognosis for different interstitial lung diseases varies considerably, with some conditions showing reversibility or stabilization, while others lead to respiratory failure and death. Recent advances in the field have led to the approval of drugs for the treatment of specific interstitial lung diseases, including systemic sclerosis-associated interstitial lung disease, interstitial lung disease-associated pulmonary hypertension, and progressive pulmonary fibrosis.

LANCET (2022)

Add to Collection

Article Nutrition & Dietetics

The Dietary Inflammatory Index and Early COPD: Results from the National Health and Nutrition Examination Survey

Chen Chen et al.

Summary: This study found that a higher consumption of a pro-inflammatory diet is associated with an increased risk of early COPD and lower lung function. These findings highlight the importance of dietary interventions as part of a healthy lifestyle to preserve lung function and prevent or improve COPD.

NUTRIENTS (2022)

Add to Collection

Review Immunology

A Glimpse Into the Microbiome of Sjogren's Syndrome

Chuiwen Deng et al.

Summary: Sjogren's syndrome, a common chronic autoimmune disease, is associated with microbial dysbiosis. The alterations in the microbiota correlate with disease severity.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection

Article Immunology

Bidirectional crosstalk between dysbiotic gut microbiota and systemic lupus erythematosus: What is new in therapeutic approaches?

Hasnaa Yaigoub et al.

Summary: This article discusses the relationship between gut microbiota and systemic lupus erythematosus, highlighting the association between gut dysbiosis and the development of autoimmune diseases. It also proposes targeting gut microbiota as a potential therapeutic approach for SLE.

CLINICAL IMMUNOLOGY (2022)

Add to Collection

Review Microbiology

Gut microbiome and metabolites: The potential key roles in pulmonary fibrosis

Yinlan Wu et al.

Summary: Recent studies have shown a relationship between changes in the gut microbiome and metabolites with fibrotic interstitial lung disease. Understanding these effects may provide new possibilities for the prevention, diagnosis, and treatment of pulmonary fibrosis.

FRONTIERS IN MICROBIOLOGY (2022)

Add to Collection

Review Immunology

Safety and efficacy of probiotic supplementation in 8 types of inflammatory arthritis: A systematic review and meta-analysis of 34 randomized controlled trials

Liuting Zeng et al.

Summary: Probiotic supplementation may be safe and effective in the treatment of inflammatory arthritis, with potential improvements in various types of symptoms. However, more randomized controlled trials are needed to determine the specific efficacy and optimal dosing design of probiotics.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection

Review Immunology

Gut microbiota and rheumatoid arthritis: From pathogenesis to novel therapeutic opportunities

Ting Zhao et al.

Summary: RA is a chronic autoimmune disease primarily affecting joints, with microbial infection being a crucial trigger. Changes in gut microbiota composition are closely linked to immune dysfunction in RA. Better understanding of gut microbiota alterations can aid in the development of novel therapeutic approaches.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection

Article Rheumatology

Altered Gut Microbiome in Patients With Dermatomyositis

Sangmee Sharon Bae et al.

Summary: This study compared the microbial composition between patients with dermatomyositis (DM) and healthy controls (HCs), and found that patients with DM, particularly those with interstitial lung disease (ILD)-associated myositis-specific autoantibodies (MSAs), have lower microbial diversity and a distinct taxonomic composition. Predictive metagenomics analysis also revealed functional alterations in multiple metabolic pathways, specifically those involved in lipopolysaccharide synthesis and transport.

ACR OPEN RHEUMATOLOGY (2022)

Add to Collection

Article Rheumatology

Disease Features and Gastrointestinal Microbial Composition in Patients with Systemic Sclerosis from Two Independent Cohorts

Kristofer Andreasson et al.

Summary: The study aims to investigate the alterations in gastrointestinal microbial composition in patients with systemic sclerosis (SSc) and its relationship with SSc features. Dysbiosis was observed in patients recently diagnosed with SSc. Disease duration, interstitial lung disease, small intestinal bacterial overgrowth, and immunosuppression use were associated with fecal microbial composition in SSc patients. Abundance of several pathobiont bacteria differed between the cohorts, suggesting the importance of considering environmental factors in future SSc studies.

ACR OPEN RHEUMATOLOGY (2022)

Add to Collection

Article Critical Care Medicine

The Respiratory Microbiome in Chronic Hypersensitivity Pneumonitis Is Distinct from That of Idiopathic Pulmonary Fibrosis

Rachele Invernizzi et al.

Summary: The study found distinct differences in the lower airway microbial profiles of patients with Chronic Hypersensitivity Pneumonitis (CHP) and Idiopathic Pulmonary Fibrosis (IPF), with CHP patients' bacterial burden failing to predict survival.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Butyrate Improves Skin/Lung Fibrosis and Intestinal Dysbiosis in Bleomycin-Induced Mouse Models

Hee Jin Park et al.

Summary: The study found that butyrate has potential therapeutic effects in a mouse model of SSc and human dermal fibroblasts, by modulating intestinal microbiota, controlling macrophage differentiation, and inhibiting proinflammatory gene expression, thus improving fibrosis.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Add to Collection

Article Rheumatology

Dynamic Changes in the Nasal Microbiome Associated With Disease Activity in Patients With Granulomatosis With Polyangiitis

Rennie L. Rhee et al.

Summary: The study found significant temporal changes in the nasal microbiome of GPA patients, which are associated with disease activity. The changes in nasal bacteria occurring months before relapse support a pathogenic role of nasal bacteria in GPA.

ARTHRITIS & RHEUMATOLOGY (2021)

Add to Collection

Review Medicine, General & Internal

Role of the Microbiome in Interstitial Lung Diseases

Ozioma S. Chioma et al.

Summary: The microbiome in the human body comprises trillions of microorganisms that can serve as biomarkers for disease and therapeutic targets. Recent studies highlight the impact of microorganisms in the respiratory tract on lung health, with a focus on the gut-lung axis and its potential influence on lung diseases. Dysbiosis in the gut microbial community is linked to changes in immune responses, airway homeostasis, and inflammatory conditions in the gastrointestinal tract.

FRONTIERS IN MEDICINE (2021)

Add to Collection

Review Pharmacology & Pharmacy

The Microbiota in Systemic Lupus Erythematosus: An Update on the Potential Function of Probiotics

Xirui Guo et al.

Summary: Systemic lupus erythematosus (SLE) is a chronic diffuse connective tissue illness characterized by multisystem and multiorgan involvement. Intake of probiotics alters the composition of the gut microbiome, contributing to prevent the progression of SLE and alleviate symptoms in animal models. Probiotics supplementation may serve as a potentially novel approach in the treatment of SLE.

FRONTIERS IN PHARMACOLOGY (2021)

Add to Collection

Review Immunology

Gut Microbiota Dysbiosis in Systemic Lupus Erythematosus: Novel Insights into Mechanisms and Promising Therapeutic Strategies

Quanren Pan et al.

Summary: SLE is a chronic autoimmune disease with treatment options including hormones, immunosuppressants, and biologic drugs, but rates of response are unsatisfactory. Emerging evidence suggests gut microbiota dysbiosis may play crucial roles in SLE, with potential therapies like oral antibiotic therapy and fecal microbiota transplantation showing promise. Further research and understanding of gut microbiota in SLE may provide novel therapeutic strategies for improving clinical outcomes.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Review Biochemistry & Molecular Biology

The Role of Microbiome and Virome in Idiopathic Pulmonary Fibrosis

Paschalis Ntolios et al.

Summary: The interest in the lung microbiome and virome and their contribution to the pathogenesis of idiopathic pulmonary fibrosis (IPF) has been increasing. Higher microbial burden is associated with worse prognosis but no specific microbe has been identified to contribute to this. Infection is considered a cause of acute exacerbation of IPF, but the association of viral infection with AE-IPF has not been established.

BIOMEDICINES (2021)

Add to Collection

Review Rheumatology

The microbiome in autoimmune rheumatic disease

Maximilian F. Konig

BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2020)

Add to Collection

Review Immunology

Respiratory microbiome and epithelial interactions shape immunity in the lungs

Rachele Invernizzi et al.

IMMUNOLOGY (2020)

Add to Collection

Article Multidisciplinary Sciences

Fecal microbiota transplantation in systemic sclerosis: A double-blind, placebo-controlled randomized pilot trial

Havard Fretheim et al.

PLOS ONE (2020)

Add to Collection

Review Microbiology

Host-microbiota interactions in immune-mediated diseases

William E. Ruff et al.

NATURE REVIEWS MICROBIOLOGY (2020)

Add to Collection

Review Rheumatology

Pharmacomicrobiomics in inflammatory arthritis: gut microbiome as modulator of therapeutic response

Jose U. Scher et al.

NATURE REVIEWS RHEUMATOLOGY (2020)

Add to Collection

Article Immunology

Microbiome and Metabolome Analyses Reveal the Disruption of Lipid Metabolism in Systemic Lupus Erythematosus

Jingquan He et al.

FRONTIERS IN IMMUNOLOGY (2020)

Add to Collection

Article Cell Biology

Gut microbiota dysbiosis and altered tryptophan catabolism contribute to autoimmunity in lupus-susceptible mice

Seung-Chul Choi et al.

SCIENCE TRANSLATIONAL MEDICINE (2020)

Add to Collection

Article Medicine, General & Internal

Effect of Co-trimoxazole (Trimethoprim-Sulfamethoxazole) vs Placebo on Death, Lung Transplant, or Hospital Admission in Patients With Moderate and Severe Idiopathic Pulmonary Fibrosis The EME-TIPAC Randomized Clinical Trial

Andrew M. Wilson et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Glutaminolysis Epigenetically Regulates Antiapoptotic Gene Expression in Idiopathic Pulmonary Fibrosis Fibroblasts

Le Bai et al.

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2019)

Add to Collection

Article Rheumatology

Lupus nephritis is linked to disease-activity associated expansions and immunity to a gut commensal

Doua Azzouz et al.

ANNALS OF THE RHEUMATIC DISEASES (2019)

Add to Collection

Article Dentistry, Oral Surgery & Medicine

The role of natural salivary defences in maintaining a healthy oral microbiota

Anne Marie Lynge Pedersen et al.

JOURNAL OF DENTISTRY (2019)

Add to Collection

Article Cardiac & Cardiovascular Systems

Vitamin D and disease severity in bronchiectasis

S. Ferri et al.

RESPIRATORY MEDICINE (2019)

Add to Collection

Editorial Material Cell Biology

Transforming medicine with the microbiome

Niv Zmora et al.

SCIENCE TRANSLATIONAL MEDICINE (2019)

Add to Collection

Article Pharmacology & Pharmacy

Vitamin D prevents experimental lung fibrosis and predicts survival in patients with idiopathic pulmonary fibrosis

Vasilios Tzilas et al.

PULMONARY PHARMACOLOGY & THERAPEUTICS (2019)

Add to Collection

Article Rheumatology

Effect of probiotics on gastrointestinal symptoms and immune parameters in systemic sclerosis: a randomized placebo-controlled trial

Thais Fernandes Marighela et al.

RHEUMATOLOGY (2019)

Add to Collection

Article Medicine, General & Internal

Nintedanib in Progressive Fibrosing Interstitial Lung Diseases

K. R. Flaherty et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Add to Collection

Article Microbiology

The composition and functional protein subsystems of the human nasal microbiome in granulomatosis with polyangiitis: a pilot study

Josef Wagner et al.

MICROBIOME (2019)

Add to Collection

Article Microbiology

A Diet-Sensitive Commensal Lactobacillus Strain Mediates TLR7-Dependent Systemic Autoimmunity

Daniel F. Zegarra-Ruiz et al.

CELL HOST & MICROBE (2019)

Add to Collection

Article Immunology

Changes in the composition of the upper respiratory tract microbial community in granulomatosis with polyangiitis

Peter Lamprecht et al.

JOURNAL OF AUTOIMMUNITY (2019)

Add to Collection

Article Rheumatology

Relationship Between Increased Fecal Calprotectin Levels and Interstitial Lung Disease in Systemic Sclerosis

Cristian Caimmi et al.

JOURNAL OF RHEUMATOLOGY (2019)

Add to Collection

Article Multidisciplinary Sciences

Microbial and metabolic multi-omic correlations in systemic sclerosis patients

Chiara Bellocchi et al.

ANNALS OF THE NEW YORK ACADEMY OF SCIENCES (2018)

Add to Collection

Review Biochemistry & Molecular Biology

Biomarkers in idiopathic pulmonary fibrosis

F. Drakopanagiotakis et al.

MATRIX BIOLOGY (2018)

Add to Collection

Article Rheumatology

Characterisation of the nasal microbiota in granulomatosis with polyangiitis

Rennie L. Rhee et al.

ANNALS OF THE RHEUMATIC DISEASES (2018)

Add to Collection

Review Immunology

Contributions of the intestinal microbiome in lung immunity

Jeremy P. McAleer et al.

EUROPEAN JOURNAL OF IMMUNOLOGY (2018)

Add to Collection

Article Respiratory System

Atopobium and Fusobacterium as novel candidates for sarcoidosis-associated microbiota

Alexandra Zimmermann et al.

EUROPEAN RESPIRATORY JOURNAL (2017)

Add to Collection

Article Dermatology

Early-Life Antibiotic Exposure Causes Intestinal Dysbiosis and Exacerbates Skin and Lung Pathology in Experimental Systemic Sclerosis

Heena Mehta et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2017)

Add to Collection

Article Gastroenterology & Hepatology

The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics

Glenn R. Gibson et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)

Add to Collection

Article Rheumatology

Chronic nasal Staphylococcus aureus carriage identifies a subset of newly diagnosed granulomatosis with polyangiitis patients with high relapse rate

Anna Salmela et al.

RHEUMATOLOGY (2017)

Add to Collection

Article Rheumatology

Anti-Citrullinated Protein Antibodies Are Associated With Neutrophil Extracellular Traps in the Sputum in Relatives of Rheumatoid Arthritis Patients

M. Kristen Demoruelle et al.

ARTHRITIS & RHEUMATOLOGY (2017)

Add to Collection

Article Multidisciplinary Sciences

Gut microbiota profile in systemic sclerosis patients with and without clinical evidence of gastrointestinal involvement

Vania Patrone et al.

SCIENTIFIC REPORTS (2017)

Add to Collection

Review Respiratory System

Long-term macrolides in diffuse interstitial lung diseases

Paola Faverio et al.

EUROPEAN RESPIRATORY REVIEW (2017)

Add to Collection

Article Gastroenterology & Hepatology

Systemic sclerosis is associated with specific alterations in gastrointestinal microbiota in two independent cohorts

Elizabeth R. Volkmann et al.

BMJ OPEN GASTROENTEROLOGY (2017)

Add to Collection

Article Medicine, Research & Experimental

Chronic microaspiration of bile acids induces lung fibrosis through multiple mechanisms in rats

Bi Chen et al.

CLINICAL SCIENCE (2017)

Add to Collection

Article Microbiology

Microbial Respiration and Formate Oxidation as Metabolic Signatures of Inflammation-Associated Dysbiosis

Elizabeth R. Hughes et al.

CELL HOST & MICROBE (2017)

Add to Collection

Article Rheumatology

Association of Systemic Sclerosis With a Unique Colonic Microbial Consortium

Elizabeth R. Volkmann et al.

ARTHRITIS & RHEUMATOLOGY (2016)

Add to Collection

Article Immunology

Hand to Mouth: A Systematic Review and Meta-Analysis of the Association between Rheumatoid Arthritis and Periodontitis

Nicholas R. Fuggle et al.

FRONTIERS IN IMMUNOLOGY (2016)

Add to Collection

Article Microbiology

The lung microbiota in early rheumatoid arthritis and autoimmunity

Jose U. Scher et al.

MICROBIOME (2016)

Add to Collection

Article Multidisciplinary Sciences

Th17 responses and natural IgM antibodies are related to gut microbiota composition in systemic lupus erythematosus patients

Patricia Lopez et al.

SCIENTIFIC REPORTS (2016)

Add to Collection

Article Microbiology

Application of a Neutral Community Model To Assess Structuring of the Human Lung Microbiome

Arvind Venkataraman et al.

MBIO (2015)

Add to Collection

Article Respiratory System

The Gut-Lung Axis in Respiratory Disease

Benjamin J. Marsland et al.

ANNALS OF THE AMERICAN THORACIC SOCIETY (2015)

Add to Collection

Article Respiratory System

Spatial Variation in the Healthy Human Lung Microbiome and the Adapted Island Model of Lung Biogeography

Robert P. Dickson et al.

ANNALS OF THE AMERICAN THORACIC SOCIETY (2015)

Add to Collection

Article Critical Care Medicine

Comparison of the Respiratory Microbiome in Healthy Nonsmokers and Smokers

Alison Morris et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)

Add to Collection

Article Rheumatology

Periodontal disease and the oral microbiota in new-onset rheumatoid arthritis

Jose U. Scher et al.

ARTHRITIS AND RHEUMATISM (2012)

Add to Collection

Article Multidisciplinary Sciences

Human gut microbiome viewed across age and geography

Tanya Yatsunenko et al.

NATURE (2012)

Add to Collection

Article Multidisciplinary Sciences

Analysis of the Lung Microbiome in the Healthy Smoker and in COPD

John R. Erb-Downward et al.

PLOS ONE (2011)

Add to Collection

Article Respiratory System

Pulmonary infection in Wegener granulomatosis and idiopathic pulmonary fibrosis

A. G. Richter et al.

THORAX (2009)

Add to Collection

Article Medicine, Research & Experimental

CO-TRIMOXAZOLE AND PREVENTION OF RELAPSES OF PR3-ANCA POSITIVE VASCULITIS WITH PULMONARY INVOLVEMENT

K. Zycinska et al.

EUROPEAN JOURNAL OF MEDICAL RESEARCH (2009)

Add to Collection

Article Rheumatology

Staphylococcal toxic-shock-syndrome-toxin-1 as a risk factor for disease relapse in Wegener's granulomatosis

E. R. Popa et al.

RHEUMATOLOGY (2007)

Add to Collection

© Peeref 2019-2024. All rights reserved.